P001 Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on the IL23/IFNg axis. (21st January 2022)

• Record Type: Journal Article
• Authors: Lo, J; Cozzetto, D; Madgwick, M; Sieh, J Y X S; Olbei, M; Alexander, J L; Miguens Blanco, J; Kudo, H; Ibraheim, H; Liu, Z; Castro Seoane, R; Goldin, R; Marchesi, J; Korcsmaros, T; Lord, G; Powell, N
• Is Part Of: Journal of Crohn's and colitis. Volume 16(2022)Supplement 1
• Page Start: i135
• Page End: i135
• Publication Date: 2022-01-21
• Subjects: Inflammatory bowel diseases -- Periodicals; 616.344005
• DOI: 10.1093/ecco-jcc/jjab232.130
• Languages: English
• ISSNs: 1873-9946

Abstract

Abstract: Background: Immune checkpoint inhibitors (CPI) have revolutionised cancer treatment, with previously untreatable disease now amenable to potential cure. Combination regimens of anti-CTLA4 and anti-PD-1 show enhanced efficacy but are prone to off target immune-mediated tissue injury, particularly at the barrier surfaces. CPI-induced colitis is a common a serious complication. Methods: To probe the impact of immune checkpoints on intestinal homeostasis mice were challenged with combination anti-CTLA4 and anti-PD-1 immunotherapy, manipulation of the intestinal microbiota and antibody blockade/depletion studies. Colonic immune responses were profiled using RNA-sequencing, including high-resolution single cell analyses, and flow cytometry. Results: CPI colitis was dependent on the composition of the intestinal microbiota and was characterized by remodelling of mucosal lymphocytes with induction of polyfunctional lymphocyte responses characterized by expression of interferon-g (IFNg), other pro-inflammatory cytokines/chemokines ( Il22, Il17a Ccl3, Ccl4 and Ccl9 ) and cytotoxicity molecules ( Gzmb, Gzma, Prf1, Nkg7 ). In comparison with mucosal lymphocytes in the steady state, polyfunctional lymphocytes from both CD4 + and CD8 + lineages upregulated costimulatory molecules and checkpoint molecules in CPI-colitis, indicating that these cells are usually very tightly regulated. CPI-colitis was attenuated following depletion of effector lymphocytes or following blockade of the IL23/IFNg axis. Conclusion: This study provides new mechanistic insights into CPI-colitis, identifying polyfunctional, cytotoxic lymphocytes as key mediators of disease. Therapeutic targeting of their effector response or regulatory networks, including the IL23/IFNg axis holds the key to preventing and reversing CPI-colitis.